Trials / Completed
CompletedNCT03826316
Pharmacokinetics of Nalbuphine Injection
A Study to Evaluate Pharmacokinetics of Nalbuphine Hydrochloride (10 mg/mL) After a Single Intravenous Administration in Healthy Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Yung Shin Pharm. Ind. Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate pharmacokinetics of nalbuphine hydrochloride (10 mg/mL) after a single intravenous administration in healthy volunteers under fasting conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nalbuphine | Pharmacokinetic study under fasting conditions |
Timeline
- Start date
- 2018-01-15
- Primary completion
- 2018-11-22
- Completion
- 2019-01-15
- First posted
- 2019-02-01
- Last updated
- 2019-02-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03826316. Inclusion in this directory is not an endorsement.